Wenjuan Zhou

Dr. Wenjuan Zhou


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Journal of Evidence-Based Dental Practice
Verified
Journal Article
Closed access
WZWenjuan Zhou
Wenjuan Zhou
ZLZhonghao Liu
Zhonghao Liu
LSLiansheng Song
Liansheng Song
CKChia-Ling Kuo
Chia-Ling Kuo
DSDavid M. Shafer
David M. Shafer

1 October 2015 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
ZLZhonghao Liu
Zhonghao Liu
WZWenjuan Zhou
Wenjuan Zhou
Stefan TanglStefan Tangl
Stefan Tangl
SLShutai Liu
Shutai Liu
XXXin Xu
Xin Xu
XRXiaohui Rausch-Fan
Xiaohui Rausch-Fan

1 February 2015 in Implant Dentistry
Verified
Journal Article
Closed access
ZLZhonghao Liu
Zhonghao Liu
HJHuanhuan Jiang
Huanhuan Jiang
KDKai Dong
Kai Dong
SLShutai Liu
Shutai Liu
WZWenjuan Zhou
Wenjuan Zhou
XXXin Xu
Xin Xu
The aim of this study was to investigate the effect of high glucose levels on proliferation and osteogenic ability in MC3T3-E1 osteoblastic cell line and to explore the regulatory mechanism of PI3 kinase (PI3K)/Akt signaling pathway. The cultures were divided into 8 treatment groups: 4 concentrations of glucose (5.5, 15.5, 25.5, and 35.5 mM) with or without LY294002. Cell proliferation, alkaline phosphatase (ALP) assay, alizarin red staining of mineralized nodule, osteogenic genes, and P-AKT expression were analyzed. Cell proliferation, ALP activity, mineralization, osteogenic genes (RUNX2, OSX, OPN, OCN) and P-AKT expression in MC3T3-E1 cells were increased, whereas the glucose concentration changed from 5.5 to 15.5 mM. However, when the glucose concentrations continue to increase from 25.5 to 35.5 mM, the proliferation and osteogenic ability in MC3T3-E1 cells were gradually declined. Furthermore, these effects were significantly inhibited by PI3K/Akt inhibitor LY294002 at a glucose concentration of 15.5 mM, which was the optimum. Appropriate high glucose concentration (15.5 mM) can increase osteogenic differentiation by activating PI3K/Akt pathway in MC3T3-E1 cells, but exorbitant high glucose concentrations (25.5 and 35.5 mM) inhibited the biomineralization process. Findings indicated that PI3K/Akt pathway plays an important role in the physiological process of MC3T3-E1 cells.

17 September 2018 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
LWLingfei Wei
Lingfei Wei
YJYuxi Jiang
Yuxi Jiang
WZWenjuan Zhou
Wenjuan Zhou
SLShutai Liu
Shutai Liu
YLYuelian Liu
Yuelian Liu
ZLZhonghao Liu
Zhonghao Liu

1 January 2023 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
KDKai Dong
Kai Dong
WZWenjuan Zhou
Wenjuan Zhou
ZLZhong-Hao Liu
Zhong-Hao Liu
Dong K, et al. J Periodontal Implant Sci. 2022 Aug;52:e30. https://doi.org/10.5051/jpis.2106240312

10 August 2012 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
SLShutai Liu
Shutai Liu
HWHuaizhou Wang
Huaizhou Wang
CQCaiqing Qiu
Caiqing Qiu
JZJing Zhang
Jing Zhang
TZTaowen Zhang
Taowen Zhang
ZLZhonghao Liu
Zhonghao Liu
Periodontitis is a chronic inflammatory disease associated with gram-negative subgingival microflora infection. Accumulating experimental evidence suggests that escin exerts anti-inflammatory and anti-edematous effects. This study was designed to investigate the in vitro effects of escin on the inflammatory reaction of human periodontal ligament cells (hPDLs). hPDLs were stimulated with lipopolysaccharide (LPS). The cells were treated with various concentrations of escin. The viability of hPDLs was evaluated using the MTT method. The expression of Toll-like receptor 2 (TLR2) in hPDLs and the levels of IL-1β, TNF-α and IL-6 in the supernatant were measured. Escin significantly attenuated LPS-induced cytotoxicity in a concentration-dependent manner in hPDLs. Treatment with escin partly blocked the expression of TLR2. Escin also lowered the increase of pro-inflammatory cytokines (IL-1β, TNF-α and IL-6) induced by LPS. The present findings show that escin exerts a protective effect against LPS-induced inflammation in hPDLs. It was also shown that escin is a promising medicine for the treatment of periodontitis.